Denise has more than 35 years of experience in the biopharmaceutical arena, including roles in sales, marketing, new business development, medical economics, health policy, reimbursement planning and market access consulting. She has been involved in the launch of more than 50 specialty drugs and biologicals, including physician-administered and oral agents within Medicare, Medicaid and commercial payer environments.DK Pierce & Associates is a certified Women's Business Enterprise company of 25 employees with experience and proficiency in clinical, reimbursement and healthcare delivery strategies for oral and physician-administered drugs and biologics, as well as diagnostics. Our company has high expertise in the nuances and dynamics of oncology, cell/gene therapies and rare diseases, with the ability to assess both the national top level issues, as well as the local healthcare delivery impact from stakeholders such as payers, providers and employers.DKP Lifecycle Solutions™ encompass in-licensing and detailed landscape analyses, to better identify the market in which a product will enter. We also facilitate qualitative in-depth marketing research with healthcare delivery stakeholders to inform clinical trial design, develop full payer launch strategies, and ultimately engage with payers to help establish coverage, coding and payment connecting the right patient with appropriate treatment options. DKP is well known for its DKP PayerScope® market monitoring services, which report on payer and healthcare market change, including implications analysis and recommendations on strategic action. The company's Government Payer group, focusing on Medicare and Medicaid, are considered experts in understanding the evolution of decision making for treatments for complex diseases such as cancer and rare diseases.Specialties: Product launch strategy development and implementation; product reimbursement market analysis; clinical compendia and oncology pathway assessments; qualitative market research; local and national payer and health system profiling and strategy development; multistakeholder (payer, provider and employer ) advisory board facilitation; market trends and analytics.